Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Main Gut Bacterial Composition Differs Between Patients With Type 1 and Type 2 Diabetes and Non-Diabetic Adults Publisher



Ejtahed HS1, 2 ; Hoseinitavassol Z3 ; Khatami S4 ; Zangeneh M5 ; Behrouzi A3 ; Ahmadi Badi S3 ; Moshiri A6, 7 ; Hasaniranjbar S1 ; Soroush AR1 ; Vaziri F3 ; Fateh A3 ; Ghanei M8 ; Bouzari S9 ; Najarpeerayeh S10 Show All Authors
Authors
  1. Ejtahed HS1, 2
  2. Hoseinitavassol Z3
  3. Khatami S4
  4. Zangeneh M5
  5. Behrouzi A3
  6. Ahmadi Badi S3
  7. Moshiri A6, 7
  8. Hasaniranjbar S1
  9. Soroush AR1
  10. Vaziri F3
  11. Fateh A3
  12. Ghanei M8
  13. Bouzari S9
  14. Najarpeerayeh S10
  15. Siadat SD2, 3
  16. Larijani B2

Source: Journal of Diabetes and Metabolic Disorders Published:2020


Abstract

Background: Regarding the role of gut microbial dysbiosis in hyperglycemia, we aimed to compare the main gut bacterial composition among type 1 and type 2 diabetic patients and healthy non-diabetic adults. Methods: A total of 110 adult subjects (49 patients diagnosed with type 2 diabetes, 21 patients diagnosed with type 1 diabetes and 40 healthy persons) were included in this case-control study. The intestinal microbiota composition was investigated by quantitative real-time polymerase chain reaction (qPCR) method targeting bacterial 16S rRNA gene. Comparison between three groups was done using one-way analysis of variance. Results: The participants’ mean age in the type 1 diabetes, type 2 diabetes and control groups was 35.4, 57.2 and 38.0 years, respectively. Higher level of Escherichia, Prevotella and Lactobacillus was observed in both type 1 and type 2 diabetic patients compared with the healthy group (P ˂0.001). In contrast, bacterial load of Bifidobacterium, Roseburia and Bacteroides was higher in healthy control group (P < 0.05). Faecalibacterium was significantly lower in type 1 diabetic patients compared with the other two groups (P ˂0.001). No significant difference was found in Akkermansia level among three groups. Conclusions: Gut microbial alterations have been observed among patients suffering from type 1 and type 2 diabetes mellitus and healthy control adults. Butyrate producing genera including Roseburia and Faecalibacterium decreased while Escherichia, Prevotella and Lactobacillus increased in diabetic patients compared to healthy subjects. Modulating approaches of gut microbiota composition could be helpful in diabetes management. © 2020, Springer Nature Switzerland AG.
Related Docs
View other Related Docs
1. Gut Microbiota Composition in Obese and Normal Weight Adults in Iran, Journal of Mazandaran University of Medical Sciences (2021)
2. Metformin Induces Weight Loss Associated With Gut Microbiota Alteration in Non-Diabetic Obese Women: A Randomized Double-Blind Clinical Trial, European Journal of Endocrinology (2019)
3. Microbiota Research in Iran; Current Knowledge and Future Perspective, Journal of Diabetes and Metabolic Disorders (2021)
Experts (# of related papers)
View all Related Experts
Hanieh-Sadat Ejtahed (12)
Ahmadreza Soroush (9)
Other Related Docs
4. Blood Microbiota Composition in Iranian Pre-Diabetic and Type 2 Diabetic Patients, Human Antibodies (2021)
5. Intestinal Microbiota Composition in Iranian Diabetic, Pre-Diabetic and Healthy Individuals, Journal of Diabetes and Metabolic Disorders (2020)
6. Comparing the Effects of Live and Pasteurized Akkermansia Muciniphila on Management of Obesity and Diabetes, Journal of Mazandaran University of Medical Sciences (2021)
7. Gut Microbiota: A Perspective of Precision Medicine in Endocrine Disorders, Journal of Diabetes and Metabolic Disorders (2020)
8. Gut Microbiota As a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents, Hormone and Metabolic Research (2016)
9. Multidimensional Perspective of Obesity; Prevention to Treatment, Journal of Diabetes and Metabolic Disorders (2021)
10. Effects of Synbiotic Supplementation on Gut Microbiome, Serum Level of Tnf-Α, and Expression of Microrna-126 and Microrna-146A in Patients With Type 2 Diabetes Mellitus: Study Protocol for a Double-Blind Controlled Randomized Clinical Trial, Trials (2020)
11. Identification of an Intestinal Microbiota Signature Associated With Hospitalized Patients With Diarrhea, Acta Microbiologica et Immunologica Hungarica (2018)
12. Diabetes Management by Probiotics: Current Knowledge and Future Perspectives, International Journal for Vitamin and Nutrition Research (2016)
13. The First Report of Differences in Gut Microbiota Composition Between Obese and Normal Weight Iranian Subjects, Iranian Biomedical Journal (2020)
14. The Influence of Probiotics Consumption on Management of Prediabetic State: A Systematic Review of Clinical Trials, International Journal of Clinical Practice (2022)
15. Targeting Obesity Management Through Gut Microbiota Modulation by Herbal Products: A Systematic Review, Complementary Therapies in Medicine (2019)
16. Changes in the Gut Microbiota Composition and Their Relation to Dietary Intake After Bariatric Surgery, Obesity Surgery (2023)
17. The Comparison of the Gut Microbiome Composition, Serum Inflammatory Markers and Faecal Short-Chain Fatty Acids Among Individuals With Type 1 and 2 Diabetes Mellitus With Healthy Controls: A Case–Control Study, Endocrinology, Diabetes and Metabolism (2025)
18. Gut Microbiota in Nonalcoholic Fatty Liver Diseases With and Without Type-2 Diabetes Mellitus, European Journal of Gastroenterology and Hepatology (2021)
19. The Future of Diabetes Management by Healthy Probiotic Microorganisms, Current Diabetes Reviews (2017)
20. The Global Scientific Publications on Gut Microbiota in Type 2 Diabetes; a Bibliometric, Scientometric, and Descriptive Analysis, Journal of Diabetes and Metabolic Disorders (2022)